Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159

NCT00168168 is registered in ClinicalTrials.gov with Alberta Health services as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00168168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159
Lead sponsor
Alberta Health services
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2003
Completion date
February 28, 2007
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral stem cell/marrow transplant